Hacker News new | ask | show | jobs
by potatopatch 923 days ago
Any level of random sampling is a serious concern for a conglomerate like P&G with both many products and high volume. Negasmart may be able to sell for years at a substantial volume for them, at a considerably higher price compared to BRICS, before their first finding. I would like to see evidence from the FDA that they aren't just lucky on this one detection, (if it even was detected by them before doctors/parents reports.)
1 comments

It happens far more often than you'd think, and it rarely makes the news.

We're talking hundreds of times every month.

https://www.accessdata.fda.gov/scripts/ImportRefusals/index....

Not all of these are refused for being dangerous, of course. Some just have inaccurate labels or suchlike. But still hundreds of times each and every month.